Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. The company focuses on genetic cardiomyopathies characterized by aberrant mechanobiolog...

Healthcare
Singapore, Singapore
Founded 2020
29 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$80.6M
Last Round
N/A

Get the full picture

Create a free account to unlock Nuevocor's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required